Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys

American Journal of Primatology

Volumn 71, Issue 9, 2009, Pages 776-784

  Abbott, David H ^a,b,c   Tarantal, Alice F ^d,e   Dumesic, Daniel A ^f  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Reproductive Medicine and Infertility Associates   (United States)

Author keywords

Androgen excess; Anovulation; Fetal programming; Insulin resistance; LH hypersecretion; Obesity; PCOS associated male phenotype

Indexed keywords

ANDROGEN; LUTEINIZING HORMONE;

ABNORMALITY; AGE STRUCTURE; EXPERIMENTAL STUDY; HEALTH CARE; HEALTH RISK; HOMEOSTASIS; HORMONE; OBESITY; PHENOTYPE; PREGNANCY; PRIMATE; SECRETION; WOMENS HEALTH;

AGE; ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FEMALE; MACACA; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE;

AGE FACTORS; ANDROGENS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; LUTEINIZING HORMONE; MACACA MULATTA; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

CERCOPITHECIDAE; MACACA MULATTA; PRIMATES;

EID: 69349084968     PISSN: 02752565     EISSN: 10982345     Source Type: Journal    
DOI: 10.1002/ajp.20679     Document Type: Article

References (85)

1. Abbott DH, Dumesic DA, Eisner JR, Kemnitz JW, Goy RW. 1997. The prenatally androgenized female rhesus monkey as a model for polycystic ovarian syndrome. In: Azziz R, Nestler JE, Dewailly D, editors. Androgen excess disorders in women. Philadelphia: Lippencott-Raven Press. p 369-382.
2. Abbott DH, Dumesic DA, Eisner JR, Colman RJ, Kemnitz JW. 1998. Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab 9:62-67.
3. Abbott DH, Eisner JR, Colman RJ, Kemnitz J, Dumesic DA. 2002. Prenatal androgen excess programs for PCOS in female rhesus monkeys. In: Chang RJ, Dunaif A, Hiendel J, editors. Polycystic ovary syndrome. New York: Marcel Dekker, Inc. p 119-133.
4. Abbott DH, Foong SC, Barnett DK, Dumesic DA. 2004. Nonhuman primates contribute unique understanding to anovulatory infertility in women. ILAR J 45:116-131.
5. Abbott DH, Barnett DK, Bruns CM, Schramm RD, Dumesic DA. 2005. Androgen excess fetal programming of female reproduction: a developmental etiology for polycystic ovary syndrome? Hum Reprod Update 11:357-374.
6. Abbott DH, Dumesic DA, Levine JE, Dunaif A, Padmanabhan V. 2006. Animal models and fetal programming of PCOS. In: Azziz R, Nestler JE, Dewailly D, editors. Contemporary endocrinology: androgen excess disorders in women: polycystic ovary syndrome and other disorders, 2nd ed. Totowa, NJ: Humana Press Inc. p 259-272.
7. Abbott DH, Goodfriend TL, Dunaif A, Muller SJ, Dumesic DA. 2007. Increased body weight and enhanced insulin sensitivity in infant female rhesus monkeys exposed to androgen excess during early gestation. Abstract P2-348 presented at the 89th Annual Meeting of the Endocrine Society, Toronto, Canada, June 2-5.
8. Abbott DH, Barnett DK, Levine JE, Padmanbhan V, Dumesic DA, Jacoris S, Tarantal AF. 2008a. Endocrine antecedents of polycystic ovary syndrome (PCOS) in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod 79:154-163.
9. Abbott DH, Bruns CM, Barnett DK, Tarantal AF, Hoffmann SM, Zhou R, Levine JE, Dumesic DA. 2008b. Fetal origins of PCOS. In: Dunaif A, Chang RJ, Franks S, Legro RS, editors. Polycystic ovary syndrome: current controversies from the ovary to the pancreas. Totowa, NJ: Humana Press Inc. p. 87-106.
10. Arifin E, Shively CA, Register TC, Cline JM. 2008. Polycystic ovary syndrome with endometrial hyperplasia in a cynomolgus monkey (Macaca fascicularis). Vet Pathol 45:512-515.
11. Ayabe T, Tsutsumi O, Momoeda M, Yano T, Mitsuhashi N, Taketani Y. 1994. Impaired follicular growth and abnormal luteinizing hormone surge in luteal phase defect. Fertil Steril 61:652-656.
12. Billiar RB, Richardson D, Anderson E, Mahajan D, Little B. 1985. The effect of chronic and acyclic elevation of circulating androstenedione or estrone concentrations on ovarian function in the rhesus monkey. Endocrinology 116:2209-2220.
13. Billiar RB, Richardson D, Schwartz R, Posner B, Little B. 1987. Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. Am J Obstet Gynecol 157:1297-1302.
14. Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M. 2008. Natural selection on genes that underlie human disease susceptibility. Curr Biol 18:883-889.
15. Bruns CM, Baum ST, Colman RJ, Eisner JR, Kemnitz JW, Weindruch R, Abbott DH. 2004. Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metab 89:6218-6223.
16. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy II PF, Fitzpatrick LA. 2003. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568.
17. Coviello AD, Legro RS, Dunaif A. 2006. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91:492-497.
18. DeVane GW, Czekala NM, Judd HL, Yen SS. 1975. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 121:496-500.
19. Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P. 2006. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 91:3922-3927.
20. Diamanti-Kandarakis E, Panidis D. 2007. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 67:735-742.
21. Dodson KS, MacNaughton MC, Coutts JR. 1975. Infertility in women with apparently ovulatory cycles. I. Comparison of their plasma sex steroid and gonadotrophin profiles with those in the normal cycle. Br J Obstet Gynaecol 82:615-624.
22. Dumesic DA, Abbott DH, Eisner JR, Goy RW. 1997. Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil Steril 67:155-163.
23. Dumesic DA, Abbott DH, Eisner JR, Herrmann RR, Reed JE, Welch TJ, Jensen MD. 1998. Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. Fertil Steril 70:94-101.
24. Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH. 2002. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab 87:1111-1119.
25. Dumesic DA, Schramm RD, Abbott DH. 2005. Early origins of polycystic ovary syndrome (PCOS). Reprod Fertil Dev 17:349-360.
26. Dunaif A, Chang RJ, Franks S, Legro RS. 2008. Polycystic ovary syndrome: current controversies, from the ovary to the pancreas. Totowa, NJ: Humana Press. p vii.
27. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC. 2000. Polycystic ovary syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85:4047-4052.
28. Ehrmann DA. 2005. Polycystic ovary syndrome. N Engl J Med 352:1223-1236.
29. Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH. 2000. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 85:1206-1210.
30. Eisner JR, Dumesic DA, Kemnitz JW, Colman RJ, Abbott DH. 2003. Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes Res 11:279-286.
31. Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, Gooren LJ. 2003. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 58:562-571.
32. Ellinwood WE, Baughman WL, Resko JA. 1982. The effects of gonadectomy and testosterone treatment on luteinizing hormone secretion in fetal rhesus monkeys. Endocrinology 110:183-189.
33. Faiman C, Reyes FI, Dent DW, Fuller GB, Hobson WC, Thliveris JA. 1988. Effects of long-term testosterone exposure on ovarian function and morphology in the rhesus monkey. Anat Rec 222:245-251.
34. Fleming R, McQueen D, Yates RW, Coutts JR. 1995. Spontaneous follicular and luteal function in infertile women with oligomenorrhoea: role of luteinizing hormone. Clin Endocrinol (Oxf) 43:735-739.
35. Foecking EM, Szabo M, Schwartz NB, Levine JE. 2005. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expresmone pulse generator. Biol Reprod 72:1475-1483.
36. Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA. 2006. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab 91:2327-2333.
37. Fox R. 1999. Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease. Gynecol Endocrinol 13:390-393.
38. Franks S. 1995. Polycystic ovary syndrome. N Engl J Med 28:853-861.
39. Freinkel N. 1980. Banting Lecture 1980. Of pregnancy and progeny. Diabetes 29:1023-1035.
40. Goudas VT, Dumesic DA. 1997. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 26:893-912.
41. Goy RW, Robinson JA. 1982. Prenatal exposure of rhesus monkeys to patent androgens: morphological, behavioral, and physiological consequences. Banbury Rep 11:355-378.
42. Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvet E. 1993. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1599-1603.
43. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. 2001. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 86: 1318-1323.
44. James WP. 2008 The epidemiology of obesity: the size of the problem. J Intern Med 263:336-352.
45. Jimenez DF, Leapley AC, Lee CI, Tarantal AF. 2005 Fetal CD341cells in the maternal circulation and long-term microchimerism in rhesus macaques (Macaca mulatta). Transplantation 79:142-146.
46. Joseph-Horne R, Mason H, Batty S, White D, Hillier S, Urquhart M, Franks S. 2002. Luteal phase progesterone excretion in ovulatory women with polycystic ovaries. Hum Reprod 17:1459-1463.
47. Kemnitz JW, Engle MJ, Flitsch TJ, Perelman RH, Farrell PM. 1988. Nonhuman primate studies on diabetes. Carbohydrate intolerance and obesity. New York: Alan R. Liss, Inc. p 29-41.
48. Lee CI, Tarantal AF. 1995 Effects of age on the frequency, cell cycle, and lineage maturation of rhesus monkey (Macaca mulatta) CD341 and hematopoietic progenitor cells. Pediatr Res 58:315-322.
49. Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, Dunaif A. 2002. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87:2128-2133.
50. Ludwig DS. 2007. Childhood obesity-the shape of things to come. N Engl J Med 357:2325-2327.
51. Lunn SF, Fraser HM, Mason HD. 2002. Structure of the corpus luteum in the ovulatory polycystic ovary. Hum Reprod 17:111-117.
52. Mahendroo MS, Cala KM, Landrum DP, Russell DW. 1997. Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess. Mol Endocrinol 11:917-927.
53. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL, Padmanabhan V. 2004. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 145:790-798.
54. Marshall JC. 2006. Obesity in adolescent girls: is excess androgen the real bad actor? J Clin Endocrinol Metab 91:393-395.
55. Munir I, Yen HW, Geller DH, Torbati D, Bierden RM, Weitsman SR, Agarwal SK, Magoffin DA. 2004. Insulin augmentation of 17 alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 145:175-183.
56. Nelson VL, Legro RS, Strauss III JF, McAllister JM. 1999. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13:946-957.
57. Norman RJ, Dewailly D, Legro RS, Hickey TE. 2007. Polycystic ovary syndrome. Lancet 370:685-697.
58. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. 1998.Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 83:582-590.
59. Phy JL, Conover CA, Abbott DH, Zschunke MA, Walker DL, Session DR, Tummon IS, Thornhill AR, Lesnick TG, Dumesic DA. 2004. Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab 89:3561-3566.
60. Resko JA, Buhl AE, Phoenix CH. 1987. Treatment of pregnant rhesus macaques with testosterone propionate: observations on its fate in the fetus. Biol Reprod 37:1185-1191.
61. Rosenfield RL. 2007. Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92:787-796.
62. Sam S, Coviello AD, Sung YA, Legro RS, Dunaif A. 2008a. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care 31:1237-1241.
63. Sam S, Sung YA, Legro RS, Dunaif A. 2008b. Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism 57:84-89.
64. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. 2007. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 88: 1389-1395.
65. Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos JL, Pérez-Bravo F. 2002. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 45:959-964.
66. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburú B, Gazitúa R, Recabarren S, Cassorla F. 2005. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 20:2122-2126.
67. Slob AK, den Hamer R, Woutersen PJ, van der Werff ten Bosch JJ. 1983. Prenatal testosterone propionate and postnatal ovarian activity in the rat. Acta Endocrinol (Copenh) 103:420-427.
68. Steckler TL, Herkimer C, Dumesic DA, Padmanabhan V. 2009. Developmental programming: excess weight gain amplifies the effects of prenatal testosterone on reproductive cyclicity-implication to PCOS. Endocrinology.
69. Steiner RA, Clifton DK, Spies HG, Resko JA. 1976. Sexual differentiation and feedback control of luteinizing hormone secretion in the rhesus monkey. Biol Reprod 15:206-212.
70. Sullivan SD, Moenter SM. 2004. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci USA 101:7129-7134.
71. Tarantal AF. 1992 Sonographic assessment of nongravid female macaques (Macaca mulatta and Macaca fascicularis). J Med Primatol 21:308-315.
72. Tarantal AF, Gargosky SE. 1995 Characterization of the insulin-like growth factor axis in the fetal macaque (Macaca mulatta and Macaca fascicularis): a cross-sectional study. Growth Regul 5:190-198.
73. Tarantal AF, Laughlin LS, Dieter J, Tieu J, Hendrickx AG, Overstreet JW, Lasley BL. 1997. Pregnancy detection by ultrasound and chorionic gonadotropin during the periimplantation period in the macaque (Macaca fascicularis). Early Pregnancy Biol Med 4:281-290.
74. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47.
75. van Wagenen G. 1949. Accelerated growth with sexual precocity in female monkeys receiving testosterone propionate. Endocrinology 45:544-546.
76. Veiga-Kioez A, Herkimer C, Alekseyev A, Padmanabhan V. 2008. Developmental programming: rosigilitazone, an insulin sensitizer, improves insulin sensitivity and reproductive cycles in prenatal testosterone-treated female sheep. Abstract P2-495 presented at the 90th Annual Meeting of the Endocrine Society, San Francisco, CA, June 15-18.
77. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. 1998. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101:2622-2629.
78. Wagner JE, Kavanagh K, Ward GM, Auerbach BJ, Harwood Jr HJ, Kaplan JR. 2006. Old World nonhuman primate models of type 2 diabetes mellitus. ILAR J 47:259-271.
79. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF. 2006. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 91:4842-4848.
80. West C, Foster DL, Evans NP, Robinson J, Padmanabhan V. 2001. Intra-follicular activin availability is altered in prenatally-androgenized lambs. Mol Cell Endocrinol 185:51-59.
81. Wood JR, Dumesic DA, Abbott DH, Strauss JF. 2007. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 92:705-713.
82. Wu JM, Zelinski MB, Ingram DK, Ottinger MA. 2005. Ovarian aging and menopause: current theories, hypotheses, and research models. Exp Biol Med 230:818-828.
83. Yildiz BO, Yarali H, Oguz H, Bayraktar M. 2003. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2031-2036.
84. Zhou R, Bird IM, Dumesic DA, Abbott DH. 2005. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab 90:6630-6637.
85. Zhou R, Bruns CM, Bird IM, Kemnitz JW, Goodfriend TL, Dumesic DA, Abbott DH. 2007. Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol 23:438-448.